Literature DB >> 25278705

Reversible immortalization of human hepatocytes mediated by retroviral transfer and site-specific recombination.

Fan-Ying Meng1, Li Liu1, Feng-Hui Yang1, Chun-You Li1, Jun Liu1, Ping Zhou1.   

Abstract

AIM: To establish a method for the reversible immortalization of human hepatocytes, which may offer a good and safe source of hepatocytes for practical applications.
METHODS: We successfully isolated primary human hepatocytes from surgically resected liver tissue taken from a patient with liver hemangiomas. The freshly isolated cells were then immortalized with retroviral vector SSR#69 expressing simian virus 40 large T antigen (SV40T) and hygromycin-resistance genes flanked by paired loxP recombination targets.
RESULTS: The freshly isolated hepatocytes with high viability (85%) were successfully immortalized using retroviral gene transfer of SV40T. SV40T in the immortalized cells was then excised by Cre/loxP site-specific recombination. This cell population exhibited the characteristics of differentiated hepatocytes.
CONCLUSION: We successfully established reversibly immortalized human hepatocytes, which will provide an unlimited supply of cells for practical applications.

Entities:  

Keywords:  Hepatocyte; Hepatocyte isolation; Primary human hepatocytes; Reversible immortalization; SV40T

Mesh:

Substances:

Year:  2014        PMID: 25278705      PMCID: PMC4177490          DOI: 10.3748/wjg.v20.i36.13119

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Functional ultrasound imaging for assessment of extracellular matrix scaffolds used for liver organoid formation.

Authors:  Ryan C Gessner; Ariel D Hanson; Steven Feingold; Avery T Cashion; Ana Corcimaru; Bryant T Wu; Christopher R Mullins; Stephen R Aylward; Lola M Reid; Paul A Dayton
Journal:  Biomaterials       Date:  2013-09-04       Impact factor: 12.479

2.  Cryopreservation of encapsulated liver spheroids for a bioartificial liver: reducing latent cryoinjury using an ice nucleating agent.

Authors:  Isobel Massie; Clare Selden; Humphrey Hodgson; Barry Fuller
Journal:  Tissue Eng Part C Methods       Date:  2011-04-20       Impact factor: 3.056

3.  The HepaRG cell line is suitable for bioartificial liver application.

Authors:  Ruurdtje Hoekstra; Geert A A Nibourg; Tessa V van der Hoeven; Mariëtte T Ackermans; Theodorus B M Hakvoort; Thomas M van Gulik; Wouter H Lamers; Ronald P Oude Elferink; Robert A F M Chamuleau
Journal:  Int J Biochem Cell Biol       Date:  2011-06-24       Impact factor: 5.085

4.  Dynamic tracking of stem cells in an acute liver failure model.

Authors:  Tarek Ezzat; Dipok Kumar Dhar; Massimo Malago; Steven W M Olde Damink
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

5.  Co-culture with mesenchymal stem cells enhances metabolic functions of liver cells in bioartificial liver system.

Authors:  Ying Yang; Jianzhou Li; Xiaoping Pan; Pengcheng Zhou; Xiaopeng Yu; Hongcui Cao; Yingjie Wang; Lanjuan Li
Journal:  Biotechnol Bioeng       Date:  2012-11-01       Impact factor: 4.530

6.  Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts.

Authors:  Pei-Xian Chen; Lu-Nan Yan; Wen-Tao Wang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

7.  MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

Authors:  X-X He; Y Chang; F-Y Meng; M-Y Wang; Q-H Xie; F Tang; P-Y Li; Y-H Song; J-S Lin
Journal:  Oncogene       Date:  2011-11-07       Impact factor: 9.867

8.  Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes.

Authors:  N Kobayashi; T Fujiwara; K A Westerman; Y Inoue; M Sakaguchi; H Noguchi; M Miyazaki; J Cai; N Tanaka; I J Fox; P Leboulch
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

9.  Combined en bloc liver/pancreas transplantation in two different patients.

Authors:  Zhi-Shui Chen; Fan-Ying Meng; Xiao-Ping Chen; Dun-Gui Liu; Lai Wei; Ji-Pin Jiang; Dun-Feng Du; Wei-Jie Zhang; Chang-Sheng Ming; Nian-Qiao Gong
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

10.  Long-term follow-up of portopulmonary hypertension patients after liver transplantation.

Authors:  Saira Khaderi; Rashid Khan; Zeenath Safdar; Rise Stribling; John M Vierling; John A Goss; Norman L Sussman
Journal:  Liver Transpl       Date:  2014-06       Impact factor: 5.799

View more
  3 in total

1.  New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.

Authors:  Jennifer R Ferrer; Attasit Chokechanachaisakul; Jason A Wertheim
Journal:  Curr Transplant Rep       Date:  2015-06-01

2.  Hepatocyte isolation from resected benign tissues: Results of a 5-year experience.

Authors:  Fan-Ying Meng; Li Liu; Jun Liu; Chun-You Li; Jian-Ping Wang; Feng-Hui Yang; Zhi-Shui Chen; Ping Zhou
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

3.  Reversibly immortalized hepatic progenitor cell line containing double suicide genes.

Authors:  Shu-Yu Fang; Chao-Qun Hu; Meng-Nan Liu; Li Tao; Yi Wang; Meng-Jia Gong; Yun He; Tong-Chuan He; Yang Bi
Journal:  Int J Mol Med       Date:  2018-08-02       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.